Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
4 Seven additional Phase 3 trials are evaluating retatrutide for obesity without osteoarthritis, type 2 diabetes, obstructive sleep apnea, chronic low back pain, liver disease, and cardiovascular outcomes
Appetite suppression is usually pronounced
We are committed to confronting the stigma linked with chronic diseases, like obesity, and expanding access to our authentic, prescription-only medicines. For more on weight management: Hims & Hers Super Bowl ad slams pricey pharma industryand fumbles FDA warnings on compounded GLP-1 drugs Exclusive: The COO of Hims & Hers was the third person to try its new weight-loss drugsand shes ready to share her story Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says
Ideal candidates typically: Have struggled with weight control despite lifestyle modification Display signs of insulin resistance or metabolic syndrome Require medical assistance to prevent progression of obesity-related diseases Exclusion criteria may include individuals with a history of certain endocrine disorders, pancreatitis, or specific gastrointestinal diseases
Avoid ignoring the urge to have a bowel movement, as suppressing this signal repeatedly can worsen constipation over time
Do you even know what you're getting
US$ 23.52
US$ 28.97
US$ 22.34
US$ 21.83
US$ 23.24
